Treatment-resistant major depressive disorder and assisted dying
نویسندگان
چکیده
منابع مشابه
Treatment-resistant major depressive disorder and assisted dying
To cite: Schuklenk U, Van de Vathorst S. J Med Ethics 2015;41:577–583. ABSTRACT Competent patients suffering from treatment-resistant depressive disorder should be treated no different in the context of assisted dying to other patients suffering from chronic conditions that render their lives permanently not worth living to them. Jurisdictions that are considering, or that have, decriminalised ...
متن کاملTreatment-resistant major depressive disorder and assisted dying: response to comments.
Competent patients suffering from treatment-resistant depressive disorder should be treated no different in the context of assisted dying to other patients suffering from chronic conditions that render their lives permanently not worth living to them. Jurisdictions that are considering, or that have, decriminalised assisted dying are discriminating unfairly against patients suffering from treat...
متن کاملIntravenous ketamine for treatment-resistant major depressive disorder.
OBJECTIVE To evaluate the literature regarding the efficacy and safety of intravenous ketamine for treatment-resistant major depressive disorder (MDD). DATA SOURCES A MEDLINE search (1966-September 2011) was performed using the terms treatment-resistant depression and ketamine. The search was restricted to articles published in English and reporting on use of ketamine in humans. STUDY SELEC...
متن کاملVortioxetine versus placebo for treatment of major depressive disorder
Introduction: Major depressive disorder is a common mental condition associated with substantial morbidity and economic burden. Approved by the FDA in September 2013 for treatment of episodes of major depressive disorder, Vortioxetine is one of the newer options available in this important area of therapeutics. Materials and methods: A comprehensive literature search (PubMed, the Cochrane libr...
متن کاملMajor depressive disorder: treatment and future perspective
Department of Neurology, Children’s Hospital, Harvard Medical School, Boston, MA, USA Beer Yaakov Mental Health Center affiliated to the Sackler School of Medicine & Tel Aviv University, POB 1, 70350, Israel *Author for correspondence: Tel.: +972 8925 8258; Fax: +972 8921 2570; [email protected] Summary Major depressive disorder is a mood disorder characterized by both severe affective and ne...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Medical Ethics
سال: 2015
ISSN: 0306-6800,1473-4257
DOI: 10.1136/medethics-2014-102458